AM occurrence is rare, and outcomes differ based on the presence of COVID-19-associated pneumonia
Less Than Half of U.S.-Based Clinical Trials Report Race/Ethnicity
Median combined enrollment of minority race/ethnicity groups was below corresponding population demographics based on census estimates
ACC: Mavacamten Cuts Need for Surgery in Hypertrophic Cardiomyopathy
After 16 weeks, 76.8 and 17.9 percent in the placebo and mavacamten groups, respectively, decided to proceed with or were eligible for surgery
ACC: Infected CV Implantable Electronic Devices Often Not Removed
Although extraction within six days is linked to lower mortality, hardware not removed in 78.9 percent of patients with infected devices
AHA Looks at CV Impact of SARS-CoV-2 Infection in Children
Current knowledge summarized about SARS-CoV-2 infection and associated CV manifestations/complications in children, young adults
COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden
ACC: Lasting Reduction in BP Seen With Radiofrequency Renal Denervation
Significant reductions in systolic and diastolic BP observed at up to 36 months following intervention versus sham control procedure
Benefits of Smoking Cessation Quantified in Patients With ASCVD
About five event-free years gained through either quitting smoking or the use of three medications combined in persistent smokers
Insomnia Linked to Recurrent MACE in Coronary Heart Disease
Association remained significant after adjustment for major coronary risk factors, comorbidity, anxiety and depression symptoms
Recommendations Updated for Management of Heart Failure
Sodium-glucose cotransporter-2 inhibitors recommended for HF with reduced, mildly reduced ejection fraction